Upregulation of GNL3 Expression Promotes Colon Cancer Cell Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition Via the Wnt/β-catenin Signaling Pathway

Overview

Journal Oncol Rep

Specialty Oncology

Date 2017 Aug 30

PMID 28849076

Citations 22

Authors

Xi Tang

Lang Zha

Hui Li

Gang Liao

Zhen Huang

Xudong Peng

Ziwei Wang

Affiliations

Soon will be listed here.

Abstract

G protein nucleolar 3 (GNL3), a nucleolar GTP-binding protein, is highly expressed in progenitor cells, stem cells, and various types of cancer cells. Therefore, it is considered to have an important role in cancer pathogenesis. GNL3 has been reported to play crucial roles in cell proliferation, cell cycle regulation, inhibition of differentiation, ribosome biogenesis, and the maintenance of stemness, genome stability and telomere integrity. Furthermore, GNL3 has recently been shown to be involved in cancer invasion and metastasis. However, the biological significance of GNL3 in the invasion and metastasis of colon cancer remains unclear. This study was performed to address this gap in knowledge. GNL3 expression was upregulated in colon cancer tissue specimens and correlated with tumor differentiation, invasion and metastasis. GNL3 overexpression promoted cell proliferation, invasion, migration and the epithelial-mesenchymal transition (EMT) in colon cancer cells. Moreover, inhibition of the EMT and the Wnt/β‑catenin signaling pathway induced by GNL3 knockdown was partially reversed by lithium chloride (LiCl). Based on these data, GNL3 promotes the EMT in colon cancer by activating the Wnt/β‑catenin signaling pathway. In summary, GNL3 is upregulated in colon cancer and plays an important role in tumor growth, invasion and metastasis. Strategies targeting GNL3 are potential treatments for colon cancer.

Citing Articles

Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer.

Omran M, Fouda M, Mekkawy S, Tabll A, Abdelaziz A, Omran A Technol Cancer Res Treat. 2024; 23:15330338241254061.

PMID: 38794896 PMC: 11128179. DOI: 10.1177/15330338241254061.

Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations.

Selheim F, Aasebo E, Reikvam H, Bruserud O, Hernandez-Valladares M Int J Mol Sci. 2024; 25(10).

PMID: 38791118 PMC: 11121526. DOI: 10.3390/ijms25105080.

Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development.

Kannampuzha S, Gopalakrishnan A, Padinharayil H, Alappat R, Anilkumar K, George A Pathogens. 2023; 12(6).

PMID: 37375460 PMC: 10305322. DOI: 10.3390/pathogens12060770.

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer.

Kumar S, Shuaib M, Alasmari A, Alqahtani F, Gupta S Cancers (Basel). 2023; 15(10).

PMID: 37345060 PMC: 10216705. DOI: 10.3390/cancers15102723.

LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway.

Zhuang Y, Ning C, Liu P, Zhao Y, Li Y, Ma Z Oncol Res. 2023; 30(6):289-300.

PMID: 37303493 PMC: 10207973. DOI: 10.32604/or.2022.028225.

References

Meng L, Lin T, Tsai R . Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci. 2008; 121(Pt 24):4037-46. PMC: 5048913. DOI: 10.1242/jcs.037952. View

Timmerman L, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares J, Diez J . Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004; 18(1):99-115. PMC: 314285. DOI: 10.1101/gad.276304. View

Hu B, Hua L, Ni W, Wu M, Yan D, Chen Y . Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27 to drive hepatocellular carcinoma progression. Cancer Lett. 2016; 388:220-229. DOI: 10.1016/j.canlet.2016.12.008. View

Lin T, Ibrahim W, Peng C, Finegold M, Tsai R . A novel role of nucleostemin in maintaining the genome integrity of dividing hepatocytes during mouse liver development and regeneration. Hepatology. 2013; 58(6):2176-87. PMC: 3844114. DOI: 10.1002/hep.26600. View

Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K . Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues. J Cancer Res Clin Oncol. 2009; 136(4):587-94. DOI: 10.1007/s00432-009-0693-2. View

Yang J, Weinberg R . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14(6):818-29. DOI: 10.1016/j.devcel.2008.05.009. View

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

Tsai R . Turning a new page on nucleostemin and self-renewal. J Cell Sci. 2014; 127(Pt 18):3885-91. PMC: 4163642. DOI: 10.1242/jcs.154054. View

Yuan X, Sun X, Shi X, Wang H, Wu G, Jiang C . USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway. Oncol Rep. 2017; 37(4):2398-2404. DOI: 10.3892/or.2017.5454. View

10.

Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S . YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014; 158(1):157-70. DOI: 10.1016/j.cell.2014.06.013. View

11.

Tsai R, McKay R . A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 2002; 16(23):2991-3003. PMC: 187487. DOI: 10.1101/gad.55671. View

12.

Bao Z, Wang Y, Yang L, Wang L, Zhu L, Ban N . Nucleostemin promotes the proliferation of human glioma via Wnt/β-Catenin pathway. Neuropathology. 2015; 36(3):237-49. DOI: 10.1111/neup.12265. View

13.

Chaudhury A, Hussey G, Ray P, Jin G, Fox P, Howe P . TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol. 2010; 12(3):286-93. PMC: 2830561. DOI: 10.1038/ncb2029. View

14.

Meng L, Lin T, Peng G, Hsu J, Lee S, Lin S . Nucleostemin deletion reveals an essential mechanism that maintains the genomic stability of stem and progenitor cells. Proc Natl Acad Sci U S A. 2013; 110(28):11415-20. PMC: 3710807. DOI: 10.1073/pnas.1301672110. View

15.

Leung C, Mak W, Kai A, Chan K, Lee T, Ng I . Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling. Oncotarget. 2016; 7(20):29371-86. PMC: 5045402. DOI: 10.18632/oncotarget.8835. View

16.

Zia-Jahromi N, Hejazi S, Panjepour M, Parivar K, Gharagozloo M . Comparison of nucleostemin gene expression in CD133+ and CD133- cell population in colon cancer cell line HT29. J Cancer Res Ther. 2014; 10(1):68-72. DOI: 10.4103/0973-1482.131375. View

17.

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View

18.

Stambolic V, Ruel L, Woodgett J . Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 1996; 6(12):1664-8. DOI: 10.1016/s0960-9822(02)70790-2. View

19.

Liu S, Cai Z, Liu Y, Dong M, Sun L, Hu G . Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J Gastroenterol. 2004; 10(9):1246-9. PMC: 4622760. DOI: 10.3748/wjg.v10.i9.1246. View

20.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View